Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026

$NDTPPress releaseJul 15, 2026, 9:15 AM ETRead the release

NDT Pharmaceuticals' subsidiary Good Salt Life reported significant online retail growth in the first half of 2026, with second-quarter sales increasing approximately 50% compared to the first quarter. Growth was driven by a more than 50% increase in Amazon sales and a 180% surge in direct-to-consumer store revenue, while Chewy metrics showed over 86% of orders came from new-to-brand customers.

Key figures

Top sku growth qoq
["85%","223%"]
Q2 sales growth qoq
approximately 50%
Dtc store growth qoq
more than 180%
Amazon sales growth qoq
more than 50%
Chewy lifetime value roas
more than 3×
Chewy new customer orders
More than 86%
Amazon unit volume growth qoq
more than 60%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.